Generic placeholder image

Current Organic Chemistry

Editor-in-Chief

ISSN (Print): 1385-2728
ISSN (Online): 1875-5348

Editorial

The Role of Heterocycles in the Fight Against Cancer

Author(s): Pooja A. Chawla

Volume 25, Issue 6, 2021

Published on: 02 March, 2021

Page: [653 - 653] Pages: 1

DOI: 10.2174/138527282506210302120319

Next »
[2]
https://www.clinicaltrials.gov/ Accessed January 28, 2021,
[3]
Prasher, P.; Sharma, M.; Zacconi, F.; Gupta, G.; Aljabali, A.A.; Mishra, V.; Tambuwala, M.M.; Kapoor, D.N.; Negi, P.; Pinto, T.J.A.; Singh, I.; Chellappan, D.K.; Dua, K. Synthesis and anticancer properties of ‘azole’ based chemotherapeutics as emerging chemical moieties: A Comprehensive Review. Curr. Organic Chem., 2021, 25(6), 654-668.
[4]
Dadashpour, S.; Emami, S. Indole in the target-based design of anticancer agents: A versatile scaffold with diverse mechanisms. Eur. J. Med. Chem., 2018, 150, 9-29.
[5]
Bansal, Y.; Minhas, R.; Singhal, A.; Arora, R.K.; Bansal, G. Benzimidazole: A multifacted nucelus for anticancer agents. Curr. Organic Chem., 2021, 25(6), 669-694.
[6]
Grover, P.; Bhardwaj, M.; Kapoor, G.; Mehta, L.; Ghai, R.; Nagarajan, K. Advances on quinazoline based congeners for anticancer potential. Curr. Organic Chem., 2021, 25(6), 695-723.
[7]
Ahmad, I. An insight into the therapeutic potential of quinazoline derivatives as anticancer agents. Med. Chem. Commun., 2017, 8(5), 871-885.
[8]
Dhuguru, J.; Skouta, R. Role of indole scaffolds as pharmacophores in the development of anti-lung cancer agents. Molecules, 2020, 25(7), 1615.
[9]
Mir, R.H. Mohi-ud-Din, R.; Wani, T.U.; Dar, M.O.; Shah, A.J.; Lone, B.; Pooja, C.; Masoodi, M.H. Indole: A privileged heterocyclic moiety in the management of cancer. Curr. Organic Chem., 2021, 25(6), 724-736.
[10]
Kapoor, B.; Gulati, M.; Gupta, R.; Singh, S.K.; Gupta, M.; Nabi, A.; Chawla, P.A. A review on plant flavonoids as potential anticancer agents. Curr. Organic Chem., 2021, 25(6), 737-747.
[11]
Chahar, M.K. Sharma, N.; Dobhal, M.P.; Joshi, Y.C. Flavonoids: A versatile source of anticancer drugs. Pharmacogn. Rev., 2011, 5(9), 1.

© 2024 Bentham Science Publishers | Privacy Policy